SMO and cancer: A thorough grasp of the subtleties of Hh pathway activation, including both autocrine and paracrine pathways, is essential for the effectiveness of targeted cancer therapies.Current therapeutic approaches, such as the use of Smoothened (Smo) inhibitors, have shown promise in the face of obstacles such drug resistance.